在遗传扩展性心肌病中风险评估和个性化治疗选择:叙述性审查
Diana-Aurora Arnautu1,2, Dragos Cozma3, Ioan-Radu Lala4
1Multidisciplinary Heart Research Center, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania.
了解遗传扩张性心肌病 (DCM) 是改善心力衰竭结果的关键. 识别基因变异有助于风险评估和为患者和家人提供个性化治疗策略.
科学领域:
- 心血管遗传学 心血管遗传学
- 分子心脏病学分子心脏病学
- 基因组医学是基因组医学.
背景情况:
- 心力衰竭,特别是扩张性心肌病 (DCM),对全球健康造成了重大负担.
- DCM是最常见的心肌病,涉及腹腔扩大和收缩性降低,具有复杂的遗传和非遗传起源.
- 了解DCM分子机制的进展对于开发有效干预措施至关重要.
研究的目的:
- 突出发现DCM遗传原因的重要性.
- 探索遗传性DCM中的基因型-表型相关性和风险分层.
- 强调个性化,基因型导向治疗DCM的潜力.
主要方法:
- 对DCM中遗传变异的当前文献的综述.
- 在家族性和零星性DCM中分析基因型-表型关系.
- 讨论基因检测在患者选择和家庭查中的作用.
主要成果:
- 遗传变异是DCM病因和易感性的重要贡献者.
- DCM表现出由遗传因素影响的广泛的表型变异性.
- 基因检测可以识别可能受益于有针对性的干预措施的个体.
结论:
- 识别遗传DCM对于准确的诊断和预后至关重要.
- 了解遗传基础有助于个性化风险评估和管理策略.
- 基因型导向治疗方法和疾病修饰药物有望改善DCM结果.
更多相关视频
08:37Sarcomere Shortening of Pluripotent Stem Cell-Derived Cardiomyocytes using Fluorescent-Tagged Sarcomere Proteins.
Published on: March 3, 2021
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
相关概念视频
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Behavioral Genetics and Its Designs
The primary methodologies used in behavior genetics include family studies, twin studies, and adoption studies, each providing unique...
Self-Report Tests of Personality
Stress Prevention and Stress Management Techniques I
Conscientiousness
Conscientious individuals tend to be organized, responsible, and disciplined. They prioritize completing tasks and following structured routines,...
